Grifols (GRFS) Operating Margin (2009 - 2026)
Grifols (GRFS) operating margin from Dec 31, 2009 to Mar 31, 2026. The current Grifols (GRFS) operating margin is 14.65%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Grifols (GRFS)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 16.43% | -0.60% |
| 2024 | 16.53% | +39.26% |
| 2023 | 11.87% | -8.02% |
| 2022 | 12.90% | +6.97% |
| 2021 | 12.06% | -35.34% |
| 2020 | 18.65% | -15.93% |
| 2019 | 22.19% | +0.15% |
| 2018 | 22.16% | -4.64% |
| 2017 | 23.24% | +0.17% |
| 2016 | 23.20% | -5.95% |
| 2015 | 24.66% | -3.52% |
| 2014 | 25.56% | -4.79% |
| 2013 | 26.85% | +6.61% |
| 2012 | 25.18% | +62.17% |
| 2011 | 15.53% | -26.62% |
| 2010 | 21.16% | -14.68% |
| 2009 | 24.81% | -0.47% |
| 2008 | 24.92% | +19.77% |
| 2007 | 20.81% | +34.35% |
| 2006 | 15.49% | N/A |
Comparison Grifols (GRFS) operating margin with competitors
Grifols (GRFS) operating margin is 14.65%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | +320.37% |
| GILD | Gilead Sciences Inc | 37.16% | +153.71% |
| NVS | Novartis AG | 31.31% | +113.77% |
| AMGN | AMGEN Inc | 30.94% | +111.24% |
| GSK | GSK Plc | 30.06% | +105.23% |
| AZN | Astrazeneca plc | 27.77% | +89.60% |
| ABBV | Abbvie Inc | 26.60% | +81.61% |
| JNJ | Johnson & Johnson | 26.58% | +81.47% |
| SNY | Sanofi | 20.18% | +37.78% |
| OGN | Organon & Company | 18.22% | +24.40% |